INDIANAPOLIS -- A recent federal appeals court ruling allows generic competition for the antidepressant drug Prozac, produced by Eli Lilly & Co. here., and many other prescriptions drugs are expected lose their patent protection in coming years, which would trigger lower prices for an array of medications, observers noted.omising cheaper, generic prices and increasing government pressure on drug-makers
Advertisement
INDIANAPOLIS -- A recent federal appeals court ruling allows generic competition for the antidepressant drug Prozac, produced by Eli Lilly & Co. here., and many other prescriptions drugs are expected lose their patent protection in coming years, which would trigger lower prices for an array of medications, observers noted.
omising cheaper, generic prices and increasing government pressure on drug-makers for more inexpensive medications, according to press reports.
"The cost of treating many illnesses will fall because of generic competition," said Leonard Yaffe, an analyst with the Bank of America, Charlotte, N.C.
